HISTRELIN ACETATE
| Brand name | SUPPRELIN LA |
|---|---|
| Active ingredient | HISTRELIN ACETATE |
| Strength | 50MG |
| Dosage form | IMPLANT |
| Route | SUBCUTANEOUS |
| Modality | Small molecule |
| FDA approval | May 2007 |
| Marketing status | RX |
| Patent | Expires | Type |
|---|---|---|
| 8062652 | June 2026 | use U-1197 |
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.